MAP - Market Access Podcast
- Business
- Health & Fitness · Medicine
- Science
Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market access , reimbursement and pricing...
Also on
Recent episodes
- Can US GLOBE and GUARD Models Really Lower Drug Prices, Brittany La Couture?
- What Will It Take to Keep Biotech Growing in Europe, Rainer Westermann?
- How Do You Build a High-Performing Team in Pharma, Dr. Maurice Kléber?
- Where Does AI Really Add Value in Market Access, Dr. Seye Abogunrin?
- Why Should Early Health Economics Move Upstream, Dr. Björn Schwander & Julie Frappier?
- How Are Data Privacy Laws Delaying Patient Access to New Treatments, Douglas Drake and Adam Skali? (Repost)
- How Did MFN Turn Swiss Pricing into an Industrial Policy Problem, Dr. Marcel Boller?
- Is the EU "Launch Obligation" Really as Scary as It Sounds, Dr. Alexander Natz?
- Dynamic Rebates, Drug Tenders & AMNOG: Is Germany Rewriting the Rules for Pharma, Thomas Hammerschmidt?
- Wie finanziert Deutschland Gesundheitsinnovation, ohne den Patientenzugang zu gefährden, Afschin Gandjour?